Researchers at Martin Luther University Halle-Wittenberg (MLU) have developed a promising new substance for targeting ...

African scientists have developed a nanoscale drug delivery system to treat pericarditis, a drug-resistant and lethal ...

There were an estimated 490,000 new cases of drug-resistant TB in 2016. Tuberculosis, a lung disease most often transmitted by breathing infected particles in the air, is the ninth leading cause of ...

A new study uncovers vulnerabilities in drug-resistant TB, offering hope for improved treatments. Rutgers Health research has uncovered why a relatively new antibiotic for tuberculosis (TB) works ...

Tuberculosis (TB), one of the leading infectious disease killers worldwide, has long posed a challenge, particularly with the rise of drug-resistant forms. However, new research offers fresh hope in ...

BOSTON (Reuters) - An experimental drug that starves the bacteria responsible for tuberculosis makes conventional therapy five times more effective against drug-resistant TB, doctors reported on ...

Tuberculosis (TB) is a serious lung disease caused by Mycobacterium tuberculosis bacteria. While it primarily affects the lungs, TB can also affect other parts of the body and lead to life threatening ...

A rapid sputum-based assay accurately detected resistance to isoniazid, fluoroquinolones, ethionamide, amikacin, kanamycin and capreomycin in people with tuberculosis symptoms, showing its potential ...

Tuberculosis (TB) is one of the oldest and deadliest infectious diseases we know. It commonly impacts the lungs, but can also ...

A recent international study found alarmingly high levels drug-resistant strains of tuberculosis (TB) in a number of countries. Researchers from the Centers for Disease Control and Prevention (CDC) ...

This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. An estimated 440,000 people had multi-drug resistant tuberculosis in ...

The World Health Organization (WHO) is on a mission to end the tuberculosis (TB) epidemic by 2035. Part of its strategy to achieve this includes reaching a TB treatment success rate of 90 percent by ...